WP1: Project management and coordination
WP2: Towards shared European Guidelines for PGx
WP3: Genotyping technology
WP4: Clinical implementation and evaluation of pre-emptive PGx
WP5: Health Technology Assessment (HTA) and cost-effectiveness analysis
WP6: Training and education of health care professionals, patients and other stakeholders
WP7: IT solutions and clinical decision support systems for incorporation in clinical workflows
WP8: Ethics, Legal and Societal Implications (ELSI)
WP9: A next step into the future: Systems pharmacology and gene-drug-drug interactions
WP10: A next step into the future: Next generation sequencing (NGS)
WP11: Dissemination and communication, including regulatory, insurance companies